Chen, Zhian
Yang, Ya’e
Shi, Xiangwen
Yang, Rensheng
Fang, Wei
Liang, Guangjin
Li, Yun
Gao, Jing
Ma, Lihua
Yang, Junchun
Pang, Rongqing
Funding for this research was provided by:
National Natural Science Foundation of China (31970515)
Yunnan Provincial Plan Project (202301AY070001-022)
Article History
Received: 23 July 2025
Accepted: 22 October 2025
First Online: 2 January 2026
Declarations
:
: This article does not include any studies involving human participants conducted by any of the authors.All animal experiments were approved by the Ethics Committee of the 920th Hospital of the Joint Logistics Support Force (Ethics 2022-070 (Department) -01,Date of approval: August 1th 2022). All experimental procedures will strictly comply with the requirements of the Ethics Committee and the Laboratory Animal Welfare Committee.The human bone marrow mesenchymal stem cells used in this study were provided by Cyagen Biosciences Inc (OriCell, Guangzhou, China). According to the source provider’s confirmation, the acquisition of human cell samples by the company was approved by their institutional ethics review committee, and written informed consent was obtained from all cell donors, explicitly agreeing to the use of their biological samples for scientific research.
: Not applicable.
: The authors declare no competing interests.